Search Results - "Shi, Jack"

Refine Results
  1. 1
  2. 2

    The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers by Shi, Jack G., Chen, Xuejun, Lee, Fiona, Emm, Thomas, Scherle, Peggy A., Lo, Yvonne, Punwani, Naresh, Williams, William V., Yeleswaram, Swamy

    Published in Journal of clinical pharmacology (01-12-2014)
    “…Baricitinib (also known as LY3009104 or INCB028050), a novel and potent small molecule inhibitor of Janus kinase family of enzymes (JAKs) with selectivity for…”
    Get full text
    Journal Article
  3. 3

    Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis by Punwani, Naresh, PhD, Scherle, Peggy, PhD, Flores, Robert, BSN, Shi, Jack, PhD, Liang, Jinjin, PhD, Yeleswaram, Swamy, PhD, Levy, Richard, MD, Williams, William, MD, Gottlieb, Alice, MD, PhD

    “…Background Janus-associated kinases (JAKs) are involved in signal transduction from a variety of cytokines implicated in the pathogenesis of psoriasis,…”
    Get full text
    Journal Article
  4. 4

    Robustness and the evolution of length control strategies in the T3SS and flagellar hook by Nariya, Maulik K., Mallela, Abhishek, Shi, Jack J., Deeds, Eric J.

    Published in Biophysical journal (07-09-2021)
    “…Bacterial cells construct many structures, such as the flagellar hook and the type III secretion system (T3SS) injectisome, that aid in crucial physiological…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers by Shi, Jack G., Chen, Xuejun, McGee, Ryan F., Landman, Robert R., Emm, Thomas, Lo, Yvonne, Scherle, Peggy A., Punwani, Naresh G., Williams, William V., Yeleswaram, Swamy

    Published in Journal of clinical pharmacology (01-12-2011)
    “…INCB018424 phosphate, a potent inhibitor of JAK enzymes with selectivity for JAK1&2, is in development for the treatment of myelofibrosis (MF). The oral dose…”
    Get full text
    Journal Article
  8. 8

    In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions by Zhang, Qiang, Zhang, Yan, Boer, Jason, Shi, Jack G, Hu, Peidi, Diamond, Sharon, Yeleswaram, Swamy

    Published in Drug metabolism and disposition (01-06-2017)
    “…Epacadostat (EPAC) is a first-in-class, orally active inhibitor of the enzyme indoleamine 2,3-dioxygenase 1 and has demonstrated promising clinical activity…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mathematical Model for Length Control by the Timing of Substrate Switching in the Type III Secretion System by Nariya, Maulik K, Israeli, Johnny, Shi, Jack J, Deeds, Eric J

    Published in PLoS computational biology (01-04-2016)
    “…Type III Secretion Systems (T3SS) are complex bacterial structures that provide gram-negative pathogens with a unique virulence mechanism whereby they grow a…”
    Get full text
    Journal Article
  11. 11

    Population Pharmacokinetic and Pharmacodynamic Modeling of Epacadostat in Patients With Advanced Solid Malignancies by Shi, Jack G., Bowman, Kevin J., Chen, Xuejun, Maleski, Janet, Leopold, Lance, Yeleswaram, Swamy

    Published in Journal of clinical pharmacology (01-06-2017)
    “…Epacadostat (EPA, INCB024360) is a selective inhibitor of the enzyme indoleamine 2,3‐dioxygenase 1 (IDO1) and is being developed as an orally active…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Micromechanical model for self-organized secondary phase oxide nanorod arrays in epitaxial YBa2Cu3O7−δ films by Shi, Jack J., Wu, Judy Z.

    Published in Philosophical magazine (Abingdon, England) (11-08-2012)
    “…A micromechanical model based on the theory of elasticity has been developed to study the configuration of self-assembled secondary phase oxide nanostructures…”
    Get full text
    Journal Article
  15. 15

    Roles of UGT, P450, and Gut Microbiota in the Metabolism of Epacadostat in Humans by Boer, Jason, Young-Sciame, Ruth, Lee, Fiona, Bowman, Kevin J, Yang, Xiaoqing, Shi, Jack G, Nedza, Frank M, Frietze, William, Galya, Laurine, Combs, Andrew P, Yeleswaram, Swamy, Diamond, Sharon

    Published in Drug metabolism and disposition (01-10-2016)
    “…Epacadostat (EPA, INCB024360) is a first-in-class, orally active, investigational drug targeting the enzyme indoleamine 2,3-dioxygenase 1 (IDO1). In Phase I…”
    Get full text
    Journal Article
  16. 16

    Medical students’ experience of the hidden curriculum around primary care careers: a qualitative exploration of reflective diaries by Parekh, Ravi, Jones, Melvyn Mark, Singh, Surinder, Yuan, Jack Shi Jie, Chan, See Chai Carol, Mediratta, Saniya, Smith, Rhys, Gunning, Elinor, Gajria, Camille, Kumar, Sonia, Park, Sophie

    Published in BMJ open (29-07-2021)
    “…ObjectivesPrimary healthcare internationally is facing a workforce crisis with fewer junior doctors choosing general practice (GP) as a career. In the UK, a…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Potential Underprediction of Warfarin Drug Interaction From Conventional Interaction Studies and Risk Mitigation: A Case Study With Epacadostat, an IDO1 Inhibitor by Shi, Jack G., Chen, Xuejun, Punwani, Naresh G., Williams, William V., Yeleswaram, Swamy

    Published in Journal of clinical pharmacology (01-11-2016)
    “…Drug–drug interaction (DDI) studies involving warfarin are typically conducted with subtherapeutic doses of warfarin to ensure the safety of volunteers…”
    Get full text
    Journal Article
  19. 19

    Structural transition of secondary phase oxide nanorods in epitaxial YBa2Cu3O7−δ films on vicinal substrates by Shi, Jack J., Wu, Judy Z.

    Published in Philosophical magazine (Abingdon, England) (01-12-2012)
    “…A theoretical study of a structural transition of secondary phase oxide nanorods in epitaxial YBa 2 Cu 3 O 7−δ films on vicinal SrTiO 3 substrates is…”
    Get full text
    Journal Article
  20. 20

    Construction of a two-parameter empirical model of left ventricle wall motion using cardiac tagged magnetic resonance imaging data by Shi, Jack J, Alenezy, Mohammed, Smirnova, Irina V, Bilgen, Mehmet

    Published in Biomedical engineering online (24-10-2012)
    “…A one-parameter model was previously proposed to characterize the short axis motion of the LV wall at the mid-ventricle level. The single parameter of this…”
    Get full text
    Journal Article